Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by James N Ingle

1-50 of 374 results

View this query on the Wikidata Query Service
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

scientific article (publication date: 20 October 2005)
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer

scientific article published on 9 October 2003
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

scientific article
Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

article
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

scientific article
Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer

scientific article published in March 2003
Exemestane for breast-cancer prevention in postmenopausal women

scientific article published on 4 June 2011
American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer

scientific article published on 8 September 2003
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

scientific article
Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

scientific article
Centrosome hypertrophy in human breast tumors: Implications for genomic stability and cell polarity

scientific article published on March 17, 1998
HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

article
The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen

scientific article
Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells

scientific article
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial

scientific article
Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen

scientific article
Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer

scientific article published on August 21, 2013
Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).

scientific article published in February 2003
Adjuvant ovarian suppression in premenopausal breast cancer

scientific article
A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast

scientific article published on May 2, 2013
HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial

scientific article published on 01 July 2006
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

scientific article
Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention

scientific article
Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging

scientific article published on 27 July 2009
Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors

scientific article
Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.

scientific article published on 10 March 2008
TGFβ/TNFα-Mediated Epithelial–Mesenchymal Transition Generates Breast Cancer Stem Cells with a Claudin-Low Phenotype

scientific article published on May 9, 2011
Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline

scientific article published on 23 May 2016
A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer

scientific article (publication date: May 2003)
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel

scientific article
Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer

scientific article published on 01 January 1981
Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer

scientific article published in August 1990
Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group

scientific article published on 13 October 2009
Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial

scientific article
HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial

scientific article
Sequential Versus Concurrent Trastuzumab in Adjuvant Chemotherapy for Breast Cancer

scientific article published on October 31, 2011
The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cells

scientific article
Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831

scientific article published on 01 June 2002
Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model

scientific article
Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17

scientific article published on 05 July 2006
Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women

scientific article
Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial

scientific article published on 28 January 2013
Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer

scientific article published on 12 February 2008
Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196

scientific article
Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer

scientific article published on 9 December 2013
CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations

scientific article published on 23 September 2013
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.

scientific article
Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen

scientific article published on 10 March 2008
A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen

scientific article
The molecular etiology of breast cancer: evidence from biomarkers of risk

scientific article published on May 2008

Paulina is supported by:

About Paulina

Help